Complementary medicine use by patients with inflammatory bowel disease

Hilsden, Robert J.; Scott, Cathie; Verhoef, Marja J.

doi:10.1016/s0002-9270(98)00088-4

Cited by 46 publications

(53 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[4] In comparison to that sample, our current sample is slightly older (mean age 46 vs. 40 years), contains fewer females (61% vs. 68%) and is better educated (73% vs. 64% with education beyond high-school degree). However, as expected, the current sample also contains more people with less severe Crohn's disease as shown by lower rate of hospitalizations (83% vs. 92%) and surgery (65% vs. 79%) and, although measured in different ways in the two studies, probably less use of oral and iv corticosteroids.…”

Section: Discussionmentioning

confidence: 97%

See 1 more Smart Citation

A national survey on the patterns of treatment of inflammatory bowel disease in Canada

et al. 2003

View full text Add to dashboard Cite

BackgroundThere is a general lack of information on the care of inflammatory bowel disease (IBD) in a broad, geographically diverse, non-clinic population. The purposes of this study were (1) to compare a sample drawn from the membership of a national Crohn's and Colitis Foundation to published clinic-based and population-based IBD samples, (2) to describe current patterns of health care use, and (3) to determine if unexpected variations exist in how and by whom IBD is treated.MethodsMailed survey of 4453 members of the Crohn's and Colitis Foundation of Canada. The questionnaire, in members stated language of preference, included items on demographic and disease characteristics, general health behaviors and current and past IBD treatment. Each member received an initial and one reminder mailing.ResultsQuestionnaires were returned by 1787, 913, and 128 people with Crohn's disease, ulcerative colitis and indeterminate colitis, respectively. At least one operation had been performed on 1159 Crohn's disease patients, with risk increasing with duration of disease. Regional variation in surgical rates in ulcerative colitis patients was identified. 6-Mercaptopurine/Azathioprine was used by 24% of patients with Crohn's disease and 12% of patients with ulcerative colitis (95% CI for the difference: 8.9% – 15%). In patients with Crohn's disease, use was not associated with gender, income or region of residence but was associated with age and markers of disease activity. Infliximab was used by 112 respondents (4%), the majority of whom had Crohn's disease. Variations in infliximab use based on region of residence and income were not seen. Sixty-eight percent of respondents indicated that they depended most on a gastroenterologist for their IBD care. There was significant regional variation in this. However, satisfaction with primary physician did not depend on physician type (for example, gastroenterologist versus general practitioner).ConclusionThis study achieved the goal of obtaining a large, geographically diverse sample that is more representative of the general IBD population than a clinic sample would have been. We could find no evidence of significant regional variation in medical treatments due to gender, region of residence or income level. Differences were noted between different age groups, which deserves further attention.

show abstract

Section: Discussionmentioning

confidence: 97%

“…[4-8] Versions for adults (age 16 and above) and children were created. Only the results from the adult questionnaire are provided in this paper.…”

Section: Methodsmentioning

confidence: 99%

A national survey on the patterns of treatment of inflammatory bowel disease in Canada

et al. 2003

View full text Add to dashboard Cite

show abstract

“…This value drops to 36% when prayer is excluded (6). Numerous studies have evaluated the use of CAM in the adult IBD population (7–9); however, the information on CAM in the pediatric population, most of which comes from countries other than the United States, is limited. US studies that used the 1996 Medical Expenditure Panel Survey database showed an overall prevalence of childhood CAM use between 1.8% and 2%, with an annual expenditure of $149 million on CAM visits and remedies (10,11).…”

mentioning

confidence: 99%

Use of Complementary Medicine in Pediatric Patients With Inflammatory Bowel Disease: Results From a Multicenter Survey

Wong

Clark

Garnett

et al. 2009

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

Objectives We examined the use of complementary and alternative medicine (CAM) at 3 US pediatric medical centers, comparing a group of children with inflammatory bowel disease (IBD) with children presenting with chronic constipation. Materials and Methods Surveys were administered by postal mail and at pediatric IBD centers in San Francisco, Houston, and Atlanta from 2001 to 2003. A comparison group consisting of pediatric patients with chronic constipation also was surveyed. Data were analyzed by t tests and by exact tests of contingency tables. Results In all, 236 surveys were collected from the IBD group; 126 surveys were collected from the chronic constipation comparison group. CAM therapies were used by 50% in the IBD group and 23% in the chronic constipation group. The overall regional breakdown of CAM use in IBD revealed no differences, although the types of CAM therapy used varied by site. The most commonly used CAM therapies in the IBD group were spiritual interventions (25%) and nutritional supplements (25%). Positive predictors for CAM use in IBD include the patient's self-reported overall health, an increase in the number of side effects associated with allopathic medications, white ethnicity, and parental education beyond high school. Conclusions This is the first US study to characterize CAM use in pediatric patients with IBD with another chronic gastrointestinal disorder. CAM use was twice as common with the IBD group compared with the chronic constipation group. Regional variations exist with the types of CAM therapy used. Practitioners should know that half of their pediatric patients with IBD may be using CAM in conjunction with or as an alternative to other treatments and that certain predictors can help identify those using CAM therapies.

show abstract

“…[71][72][73][74][75][76] British Society of Gastroenterology Guidance on IBD highlights the need for health care professionals to have a good knowledge of disease management and an understanding of the social and emotional impact of disease for patients and their families. 1 A cross-sectional study of patients attending a GI and general medical outpatient department identified that only 20% of patients with IBD were members of the National Association for Colitis and Crohn's Disease.…”

Section: Recommendationmentioning

confidence: 99%

Contraceptive Choices for Women with Inflammatory Bowel Disease

2003

j fam plann reprod health care

View full text Add to dashboard Cite

This Guidance provides information on the effects of inflammatory bowel disease (IBD) in women of reproductive age with particular reference to contraceptive choices, fertility and pregnancy. For comprehensive advice on the management of patients with IBD, readers should refer to guidelines from the British Society for Gastroenterology.1 A key to the grades of recommendations, based on levels of evidence, is given at the end of this document. Details of the methods used by the Clinical Effectiveness Unit (CEU) in developing this Guidance, and evidence tables summarising the research basis of the recommendations, are available on the Faculty website (www.ffprhc.org.uk). Abbreviations used include: 5-aminosalicylic acid (5-ASA), body mass index (BMI), bone mineral density (BMD), combined oral contraception (COC), confidence interval (CI), copper-bearing intrauterine contraceptive device (IUD), Crohn's disease (CD), depot medroxyprogesterone acetate (DMPA), dual X-ray absorptiometry (DEXA), emergency contraception (EC), gastrointestinal (GI), incidence rate ratio (IRR), inflammatory bowel disease (IBD), levonorgestrel-releasing intrauterine system (IUS), odds ratio (OR), progestogen-only emergency contraception (POEC), progestogen-only pill (POP), anti-tumour necrosis factor-alpha (anti- TNF-a), ulcerative colitis (UC), venous thromboembolism (VTE), World Health Organization (WHO).

show abstract

Complementary medicine use by patients with inflammatory bowel disease

Abstract: Complementary medicine use is common in patients with IBD, especially among those with a longer duration of disease or a history of hospitalization.

Cited by 46 publications

References 7 publications

A national survey on the patterns of treatment of inflammatory bowel disease in Canada

A national survey on the patterns of treatment of inflammatory bowel disease in Canada

Use of Complementary Medicine in Pediatric Patients With Inflammatory Bowel Disease: Results From a Multicenter Survey

Contraceptive Choices for Women with Inflammatory Bowel Disease

Contact Info

Product

Resources

About